Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs

Japanese Journal of Pharmacology

Volumn 76, Issue 4, 1998, Pages 369-376

  Satoh, Kumi ^a   Yamamoto, Atsuko ^a   Hoshi, Katsuji ^a   Ichihara, Kazuo ^a,b  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Azelnidipine; Dihydropyridine derivative; Ischemia; Myocardial stunning

Indexed keywords

ATROPINE; AZELNIDIPINE; CALCIUM ANTAGONIST; DIMETHYL SULFOXIDE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLIC BLOOD PRESSURE; DOG; DRUG EFFECT; FEMALE; HEART MUSCLE CONTRACTILE FORCE; HIGH ENERGY PHOSPHATE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; STUNNED HEART MUSCLE;

EID: 0031960078     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.369     Document Type: Article

References (27)

1. ++ channel blocker. Jpn J Pharmacol 51, 57-64 (1989)
2. Oizumi K, Miyamoto M and Koike H: Antihypertensive effect of CS-905, a novel dihydropyridine calcium blocker, in conscious hypertensive dogs. Jpn J Pharmacol 53, 264-266 (1990)
3. Przyklenk K and Kloner RA: Calcium antagonists and the stunned myocardium. J Cardiovasc Pharmacol 18, Suppl 10, S93-S101 (1991)
4. Przyklenk K, Ghafari GB, Eitzman DT and Kloner RA: Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic stunned myocardium. J Am Coll Cardiol 13, 1176-1183 (1989)
5. Fujibayashi Y, Yamazaki S, Chang BL, Rajagopalan RE, Meerbaum S and Corday E: Comparative echocardiographic study of recovery of diastolic versus systolic function after brief periods of coronary occlusion: differential effects of intravenous nifedipine administered before and during occlusion. J Am Coll Cardiol 6, 1289-1298 (1985)
6. Lamping KA and Gross GJ: Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol 7, 158-166 (1985)
7. Applegate RJ, Walsh RA and O'Rourke RA: Effects of nifedipine on diastolic function during brief periods of flow-limiting ischemia in the conscious dog. Circulation 76, 1409-1421 (1987)
8. Gross GJ, Farber NE and Pieper GM: Effects of amlodipine on myocardial ischemia-reperfusion injury in dogs. Am J Cardiol 64, 941-1001 (1989)
9. Stopher DA, Beresford AP, Macrae PV and Humphrey MJ: The metabolism and pharmacokinetics of amlodipine in man and animals. J Cardiovasc Pharmacol 12, Suppl 7, S55-S59 (1988)
10. Lange R, Ware J and Kloner RA: Absence of a cumulative deterioration of regional function during three repeated 5 or 15 minute coronary occlusions. Circulation 69, 400-408 (1984)
11. Przyklenk K and Kloner RA: Superoxide dismutase plus catalase improve contractile function in the canine model of the 'stunned myocardium'. Circ Res 58, 148-156 (1986)
12. Ichihara K and Abiko Y: Difference between endocardial and epicardial utilization of glycogen in the ischemic heart. Am J Physiol 229, 1585-1589 (1975)
13. Bergmeyer HU (Ed): Methods of Enzymatic Analysis. Academic Press, New York (1974)
14. Atkinson DE and Walton GM: Adenosine triphosphate conversion in metabolic regulation. Rat liver citrate cleavage enzyme. J Biol Chem 242, 3239-3241 (1967)
15. Ichihara K, Morimoto T, Tsujitani M and Abiko Y: Effects of LP-805, a newly developed vasodilator, on myocardial metabolism in ischaemic dog hearts. J Pharm Pharmacol 45, 131-136 (1993)
16. Braunwald E and Kloner RA: The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66, 1146-1149 (1982)
17. Nakai T, Kano S, Satoh K, Hoshi K and Ichihara K: Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs. J Cardiovasc Pharmacol 28, 264-270 (1996)
18. Buja LM, Hagler HK and Willerson JT: Altered calcium homeostasis in the pathogenesis of myocardial ischemic and hypoxic injury. Cell Calcium 9, 205-217 (1988)
19. Boli R: Mechanism of myocardial stunning. Circulation 82, 723-738 (1990)
20. Lefer AM, Polansky EW, Bianchi CP and Narayan S: Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat. Basic Res Cardiol 74, 555-567 (1979)
21. Shridi F and Robak J: The influence of calcium channel blockers on superoxide anions. Pharmacol Res Commun 20, 13-21 (1988)
22. Mak IT and Weglicki WB: Comparative antioxidant activities of propranolol, nifedipine, verapamil and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 66, 1449-1452 (1990)
23. Ichihara K and Abiko Y: Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart. J Pharmacol Exp Ther 222, 720-725 (1982)
24. Ichihara K and Abiko Y: Rebound recovery of myocardial creatine phosphate with reperfusion after ischemia. Am Heart J 108, 1594-1597 (1984)
25. Dunlap ED, Matlib MA and Millard RW: Protection of regional mechanics and mitochondrial oxidative phosphorylation by amlodipine in transiently ischemic myocardium. Am J Cardiol 64, 841-931 (1989)
26. Packer M, Christopher CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB and Demets DL: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 335, 1107-1114 (1996)
27. Jennings RB and Ganote CE: Mitochondrial structure and function in acute myocardial ischemic injury. Circ Res 38, Suppl I, 180-191 (1976)